Anti-thyroid drugs and thyroid hormone synthesis: Effect of methimazole derivatives on peroxidase-catalyzed reactions

Journal of the American Chemical Society

Volumn 127, Issue 43, 2005, Pages 15207-15217

  Roy, Gouriprasanna ^a   Mugesh, G ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; HORMONES; ORGANOMETALLICS; SELENIUM COMPOUNDS; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

ANTI-THYROID DRUGS; LACTOPEROXIDASE (LPO); METHIMAZOLE (MMI); THYROID HARMONES;

DRUG PRODUCTS;

1 METHYLIMIDAZOLE; ANTITHYROID AGENT; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; ORGANOSELENIUM DERIVATIVE; PEROXIDASE; PROPYLTHIOURACIL; SULFUR; THIAMAZOLE; THYROID HORMONE; THYROXINE;

ARTICLE; CATALYSIS; CHEMICAL REACTION KINETICS; ENZYME INHIBITION; OXIDATION; OXIDATIVE STRESS; PHARMACOPHORE; REDUCTION; THYROID GLAND; THYROID HORMONE SYNTHESIS;

EID: 84962338794     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja054497u     Document Type: Article

References (105)

1. (a) Doerge, D. R. Xenobiotica 1985, 25, 761-767.
2. (b) Taurog, A. Thyroid Hormone Synthesis. In Werner's The Thyroid; Braverman, L. E.; Utiger, R. D., Eds. 1991, 51-97.
3. (c) Taurog, A.; Doriss, M. L.; Doerge, D. R. Arch. Biochem. Biophys. 1994, 315, 82-89.
4. (d) Doerge, D. R.; Taurog, A.; Doriss, M. L. Arch. Biochem. Biophys. 1994, 315, 90-99.
5. (e) Taurog, A.; Doriss, M. L.; Doerge, D. R. Arch. Biochem. Biophys. 1996, 330, 24-32.
6. (a) Behne, D.; Kyriakopoulos, A.; Meinhold, H.; Köhrle, J. Biochem. Biophys. Res. Commun. 1990, 173, 1143-1149.
7. (b) Berry, M. J.; Banu, L.; Larsen, P. R. Nature 1991, 349, 438-440.
8. (c) Berry, M. J.; Kieffer, J. D.; Harney, J. W.; Larsen, P. R. J. Biol. Chem. 1991, 266, 14155-14158.
9. (d) Köhrle, J. Exp. Clin. Endocrinol. 1994, 102, 63-89.
10. (e) Larsen, P. R.; Berry, M. J. Annu. Rev. Nutr. 1995, 15, 323-352.
11. (f) St. Germain, D. L.; Galton, V. A. Thyroid 1997, 7, 655-668.
12. (g) Köhrle, J. Biochimie 1999, 81, 527-553.
13. (h) du Mont, W.-W.; Mugesh, G.; Wismach, C.; Jones, P. G. Angew. Chem., Int. Ed. 2001, 40, 2486-2489.
14. (i) Bianco, A. C.; Salvatore, D.; Gereben, B.; Berry, M. J.; Larsen, P. R. Endocr. Rev. 2002, 23, 38-89.
15. (j) Köhrle, J. Methods Enzymol. 2002, 347, 125-167.
16. In addition to ID-1, two other deiodinases (ID-II and ID-III) have been shown to have selenium in their active centers (For more details, see refs 2e-j).
17. (a) Buxeraud, J.; Absil, A. C.; Claude, J.; Raby, C.; Catanzano, G.; Beck, C. Eur. J. Med. Chem. 1985, 20, 43-50.
18. (b) Raby, C.; Lagorce, J. F.; Jambut-Absil, A. C.; Buxeraud, J.; Catanzano, G. Endocrinology 1990, 126, 1683-1691.
19. Bassosi, R.; Niccolai, N.; Rossi, C. Biophys. Chem. 1978, 8, 61-69.
20. (a) Visser, T. J.; Kaptein, E.; Aboul-Enein, H. Y. Biochem. Biophys. Res. Commun. 1992, 189, 1362-1367.
21. (b) Aboul-Enein, H. Y.; Awad, A. A.; Al-Andis, N. M. J. Enzymol. Inhib. 1993, 7, 147-150.
22. (c) Taurog, A.; Dorris, M. L.; Guziec, L. J.; Guziec, F. S., Jr. Biochem. Pharmacol. 1994, 48, 1447-1453.
23. (d) Guziec, L. J.; Guziec, F. S., Jr. J. Org. Chem. 1994, 59, 4691-4692.
24. (e) Taurog, A.; Dorris, M. L.; Hu, W.-X.; Guziec, F. S., Jr. Biochem. Pharmacol. 1995, 49, 701-709.
25. Roy, G.; Nethaji, M.; Mugesh, G. J. Am. Chem. Soc. 2004, 126, 2712-2713.
26. Murai, T.; Kato, S.; Selenocarbonyls. In Topics in Current Chemistry; Wirth, T.; Ed.; Springer-Verlag, Berlin. 2000; Vol. 208, pp 177-199.
27. (a) Kjellin, G.; Sandström, J. Acta Chem. Scand. 1969, 23, 2888-2899.
28. (b) Fauré, R.; Vincent, E. J.; Assef, G.; Kister, J.; Metzger, J. Org. Magn. Reson. 1977, 9, 688-694.
29. (c) Bojarska-Olejnik, E.; Stefaniak, L.; Witanowski, M.; Hamdi, B. T.; Webb, G. A. Magn. Reson. Chem., 1985, 23, 166-169.
30. (d) Balestrero, R. S.; Forkey, D. M.; Russell, J. G. Magn. Reson. Chem. 1986, 24, 651-655.
31. Antoniadis, C. D.; Corban, G. J.; Hadjikakou, S. K.; Hadjiliadis, N.; Kubicki, M.; Warner, S. Butler, I. S. Eur. J. Inorg. Chem. 2003, 8, 1635-1640.
32. (a) Laurence, C.; El Ghomari, M. J.; Le Questel, J.-Y.; Berthelot, M.; Mokhlisse, R. J. Chem. Soc., Perkin Trans. 2 1998, 1545-1551.
33. (b) Although there is no definite evidence for the coordination of the thione moiety of the anti-thyroid drugs to the iron center, this model is given on the basis of the fact that iron-sulfur coordination is very common in metalloenzymes and hydrogen bonding of heme ligands with a distal histidine appears to be common in peroxidases. (For details, see ref 11a.)
34. Aragoni, M. C.; Arca, M.; Demartin, F.; Devillanova, F. A.; Garau, A.; Isaia, F.; Lippolis, V.; Verani, G. J. Am. Chem. Soc. 2002, 124, 4538-4539.
35. (a) Bock, H.; Aygen, S.; Rosmus, P.; Solouki, B.; Weissflog, E. Chem. Ber. 1984, 117, 187-202.
36. (b) Collin, S.; Back, T. G.; Rauk, A. J. Am. Chem. Soc. 1985, 107, 6589-6592.
37. (c) Dapprich, S.; Frenking, G. Chem. Phys. Lett. 1993, 205, 337-342.
38. (d) Kwiatkowski, J. S.; Leszczynski, J. Mol. Phys. 1994, 81, 119-131.
39. (e) Ha, T.-K.; Puebla, C. Chem. Phys. 1994, 181, 41-55.
40. (f) Jemmis, E. D.; Giju, K. T.; Leszczynski, J. J. Phys. Chem. A 1997, 101, 7389-7395.
41. (a) Sakaizumi, T.; Yasukawa, A.; Miyamoto, H.; Ohashi, O.; Yamaguchi, I. Bull. Chem. Soc. Jpn. 1986, 59, 1614-1616.
42. (b) Leszczynski, J.; Kwiatkowski, J. S.; Leszczynska, D. J. Am. Chem. Soc. 1992, 114, 10089-10091.
43. (c) Prasad, B. V.; Uppal, P.; Bassi, P. S. Chem. Phys. Lett. 1997, 276, 31-38.
44. (d) Moudgil, R.; Bharamm, P. V.; Kaur, R.; Kaur, D. Proc. Ind. Acad. Sci. (Chem. Sci.) 2002, 114, 223-230.
45. Glendening, E. D.; Hrabal, J. A., II. J. Am. Chem. Soc. 1997, 119, 12940-12946.
46. Miertus, S.; Scrocco, E.; Tomasi, J. J. Chem. Phys. 1981, 55, 117-129.
47. Nakanishi, W.; Hayashi, S. J. J. Phys. Chem. A 1999, 103, 6074-6081.
48. Visser, T. J.; Van Overmeeren, E.; Fekkes, D.; Docter, R.; Hennemann, G. FEBS Lett. 1979, 103, 314-318.
49. Kim, H.; Lee, T.-H.; Hwang, Y. S.; Bang, M. A.; Kim, K. H.; Suh, J. M.; Chung, H. K.; Yu, D.-Y.; Lee, K.-K.; Kwon, O.-Y.; Ro, H. K.; Shong, M. Mol. Pharmacol. 2001, 60, 972-980.
50. 3).
51. Mizutani, T.; Yoshida, K.; Murakami, M.; Shirai, M.; Kawazoe, S. Chem. Res. Toxicol. 2000, 13, 170-176.
52. (a) Mugesh, G.; Panda, A.; Singh, H. B.; Butcher, R. J. Chem. Eur. J. 1999, 5, 1411-1421.
53. (b) Mugesh, G.; Singh, H. B. Acc. Chem. Res. 2001, 35, 226-236.
54. Kersting, B.; Delion, M. Z. Naturforsch. 1999, 54b, 1042-1047.
55. (a) Wirth, T. Angew. Chem., Int. Ed. Engl. 1995, 34, 1726-1728.
56. (b) Wirth, T.; Fragale, G. Chem. Eur. J. 1997, 3, 1894-1902.
57. (b) Fragale, G.; Neuburger, M.; Wirth, T. J. Chem. Soc., Chem. Commun. 1998, 1867-1868.
58. (c) Déziel, R.; Goulet, S.; Grenier, L.; Bordeleau, J.; Bernier, J. J. Org. Chem. 1993, 58, 3619-3621.
59. (d) Déziel, R.; Malenfant, E. J. Org. Chem. 1995, 60, 4660-4662.
60. (c) Déziel, R.; Malenfant, E.; Bélanger, G. J. Org. Chem. 1996, 61, 1875-1876.
61. (e) Déziel, R.; Malenfant, E.; Thibault, C.; Fréchette, S.; Gravel, M. Tetrahedron Lett. 1997, 38, 4753-4756.
62. The nature of these interactions is not discussed here. For excellent articles on Se⋯X (X = N, O, etc.) interactions, see: (a) Iwaoka, M.; Tomoda, S. J. Am. Chem. Soc. 1996, 118, 8077-8084.
63. (b) Wirth, T.; Fragale, G.; Spichty, M. J. Am. Chem. Soc. 1998, 120, 3376-3381.
64. (c) Spichty, M.; Fragale, G.; Wirth, T. J. Am. Chem. Soc. 2000, 122, 10914-10916.
65. (d) Iwaoka, M.; Komatsu, H.; Katsuda, T.; Tomoda, S. J. Am. Chem. Soc. 2002, 124, 1902-1909.
66. (e) Iwaoka, M.; Komatsu, H.; Katsuda, T.; Tomoda, S. J. Am. Chem. Soc. 2004, 126, 5309-5317.
67. (f) Iwaoka, M.; Katsuda, T.; Komatsu, H.; Tomoda, S. J. Org. Chem. 2005, 70, 321-327.
68. Taurog, A.; Dorris, M. L.; Lamas, L. Endocrinology 1974, 94, 1286-1294.
69. Edelhoch, H.; Irace, G.; Johnson, M. L.; Michot, J. L.; Nunez, J. J. Biol. Chem. 1979, 254, 11822-11830.
70. Childs, R. E.; Bardsley, W. G. Biochem. J. 1975, 145, 93-103.
71. (a) Englar, H.; Taurog, A.; Luthy, C.; Dorris, M. L. Endocrinology 1983, 112, 86-95.
72. (b) Taurog, A. Endocrinology 1976, 98, 1031-1046.
73. (c) Nogimori, T.; Braverman, L. E.; Taurog, A. Fang, S.-L.; Wright, G.; Emerson, C. H. Endocrinology 1986, 118, 1598-1605.
74. (d) Taurog, A.; Dorris, M. L.; Guziec, F. S., Jr. Endocrinology 1989, 124, 30-39 and references therein.
75. (a) Doerge, D. R. Arch. Biochem. Biophys. 1986, 244, 678-685.
76. (b) Kobayashi, S.; Nakano, M.; Goto, T.; Kimura, T.; Schaap, A. P. Biochem. Biophys. Res. Commun. 1986, 135, 166-171.
77. (a) Doerge, D. R. Biochemistry 1986, 25, 4724-4728.
78. (b) Doerge, D. R.; Pitz, G. L.; Root, D. P. Biochem. Pharmacol. 1987, 36, 972-974.
79. (c) Doerge, D. R.; Takazawa, R. S. Chem. Res. Toxicol. 1990, 3, 98-101.
80. (d) Doerge, D. R.; Cooray, N. M.; Brewster, M. E. Biochemistry 1991, 30, 8960-8964.
81. Fischer, H.; Dereu, N. Bull. Soc. Chim. Belg. 1987, 96, 757-768.
82. For GPx activity of selenium compounds, see: (a) Reich, H. J.; Jasperse, C. P. J. Am. Chem. Soc. 1987, 109, 5549-5551.
83. (b) Wilson, S. R.; Zucker, P. A.; Huang, R.-R. C.; Spector, A. J. Am. Chem. Soc. 1989, 111, 5936-5939.
84. (c) Tomoda, S.; Iwaoka, M. J. Am. Chem. Soc. 1994, 116, 6, 2557-2561.
85. (d) Back, T. G.; Dyck, B. P. J. Am. Chem. Soc. 1997, 119, 2079-2083.
86. (e) Wirth, T. Molecules 1998, 3, 164-166.
87. (f) Mugesh, G.; Singh, H. B. Chem. Soc. Rev. 2000, 29, 347-357.
88. (g) Mugesh, G.; du Mont, W.-W.; Sies, H. Chem. Rev. 2001, 101, 2125-2179.
89. (h) Mugesh, G.; Panda, A.; Singh, H. B.; Punekar, N. S.; Butcher, R. J. J. Am. Chem. Soc. 2001, 123, 839-850.
90. (i) Jauslin, M.; Wirth, T.; Meier, T.; Schoumacher, F. Hum. Mol. Gen. 2002, 11, 3055-3063.
91. (j) Back, T. G.; Moussa, Z. J. Am. Chem. Soc. 2002, 124, 12104-12105.
92. (k) Back, T. G.; Moussa, Z. J. Am. Chem. Soc. 2003, 125, 13455-13460.
93. Sun, Y.; Li, T.; Chen, H.; Zhang, K.; Zheng, K.; Mu, Y.; Yan, G.; Li, W.; Shen, J.; Luo, G. J. Biol. Chem. 2004, 279, 37235-37240.
94. (a) Selenium in Biology and Human Health; Burk, R. F., Ed.; Springer-Verlag: New York, 1994.
95. (b) Tappel, A. L. Curr. Top. Cell Regul. 1984, 24, 87-97.
96. (c) Flohé, L. Curr. Top. Cell Regul. 1985, 27, 473-478.
97. (d) Epp, O.; Ladenstein, R.; Wendel, A. Eur. J. Biochem. 1983, 133, 51-69.
98. (a) Björkman, U.; Ekholm, R. Mol. Cell. Endocrinol. 1995, 111, 99-107.
99. (b) Ekholm, R.; Björkman, U. Endocrinology 1997, 138, 2871-2878.
100. 2O): δ = 13161 that could not be characterized.
101. Roveri, A.; Maiorino, M.; Ursini, F. Methods Enzymol. 1994, 233, 202-212.
102. Frisch, M. J. et al. Gaussian98; Gaussian, Inc.: Pittsburgh, PA, 1998. The full reference is given in Supporting Information.
103. (a) Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B 1988, 37, 785-789.
104. (b) Becke, A. D. J. Chem. Phys. 1993, 98, 5648-5652.
105. Glendening, E. D.; Reed, J. E.; Carpenter, J. E.; Weinhold, F. NBO Program Manual, version 3.1; University of Wisconsin, 1992.